Add BrightSurf on Google Email

Thomas Jefferson University


Over-the-counter arthritis drug might also help against MS, Jefferson neuroscientists find

Neuroscientists at Thomas Jefferson University have found that glucosamine can significantly delay the onset of multiple sclerosis (MS) symptoms and improve movement in animal models. The anti-inflammatory effects of glucosamine may be useful in conjunction with existing treatments to help patients manage MS-related debilitating effects.

SourceThomas Jefferson University·JournalThe Journal of Immunology·DateNov 28, 2005

Jefferson scientists design method to fight artificial implant infections with antibiotics

Researchers at Jefferson Medical College have developed a bonding method to create a permanent chemical bond between antibiotics and titanium, allowing it to kill bacteria and prevent infection. This technique has the potential to combat implant-related infections by creating an antibiotic surface that prevents infection from starting.

SourceThomas Jefferson University·JournalChemistry & Biology·DateSep 23, 2005

Jefferson scientists create plant factories churning out antibodies against tumor cells

Researchers from Thomas Jefferson University have successfully created plant factories that produce antibodies against tumor cells, offering a potential alternative to expensive and traditional methods. The plant-made antibodies show similar effectiveness in inhibiting tumor growth as mammalian-made monoclonal antibodies.

SourceThomas Jefferson University·JournalProceedings of the National Academy of Sciences·DateMay 3, 2005

Uric acid may help reduce effects of spinal cord injury, Jefferson researchers find

Researchers at Thomas Jefferson University found that uric acid treatment can prevent inflammation and some damage in mice with spinal cord injuries. Uric acid protected spinal cord neurons from peroxynitrite-related damage, allowing mice to recover motor function faster and to a greater extent than those treated with saline.

SourceThomas Jefferson University·JournalProceedings of the National Academy of Sciences·DateFeb 14, 2005

Jefferson virologists coax HIV out of hiding

Researchers at Thomas Jefferson University have discovered that interleukin-7 (IL-7) can stimulate latent HIV viruses, making them vulnerable to drugs and the immune system. The new technique may lead to improved treatments for HIV infection and could be a step towards complete viral eradication.

SourceThomas Jefferson University·JournalJournal of Clinical Investigation·DateJan 3, 2005

Jefferson scientists reveal how some types of rabies invade the brain

Jefferson scientists discovered that certain parts of the silver-haired bat rabies virus, specifically its glycoprotein cover, enable it to infect the brain rapidly. The researchers found that this type of rabies is capable of evading the immune system more effectively than other strains, making it a key factor in viral pathogenesis.

SourceThomas Jefferson University·JournalProceedings of the National Academy of Sciences·DateNov 14, 2004

Jefferson researchers develop microchip to track genetic signature of cancer and normal tissue

Researchers at Thomas Jefferson University have developed a microarray chip that can track the genetic signature of cancer and normal tissue by analyzing miRNA gene expression patterns. This technology has the potential to provide new targets for drug development and improve our understanding of cancer phenotypes.

SourceThomas Jefferson University·JournalProceedings of the National Academy of Sciences·DateJun 22, 2004

Jefferson scientists find how HIV causes dementia

Researchers at Jefferson Medical College have found that the HIV virus produces proteins that trigger biochemical pathways in the brain, resulting in brain cell death and dementia. The study suggests that removing the virus or its associated proteins may be an effective way to prevent or treat HIV-related dementia.

SourceThomas Jefferson University·JournalProceedings of the National Academy of Sciences·DateApr 19, 2004